Safety and Tolerability of an Intravenously-administered Alpha1-Proteinase Inhibitor (A1PI) at an Increased Infusion Rate: A Randomized, Placebo-Controlled, Phase 4 Study in Healthy Adults

Safety and Tolerability of an Intravenously-administered Alpha1-Proteinase Inhibitor (A1PI) at an Increased Infusion Rate: A Randomized, Placebo-Controlled, Phase 4 Study in Healthy Adults

Saved in:
Bibliographic Details
Published in:Chest Vol. 144; no. 4; p. 712A
Main Authors: Haeberle, Adam, PhD, Ngo, Leock, PhD, Inhaber, Niel, MD, Gelmont, David, MD, Yel, Leman, MD
Format: Conference Proceeding
Language:English
Published: Elsevier Inc 2013
Subjects:
Pulmonary/Respiratory
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0012-3692
1931-3543
DOI:10.1378/chest.1689245